[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353145-105":59,"doc-detail-353145-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","challenges-and-emerging-strategies-for-genome-wide-evaluation-of-loss-of-imprinting-in-cancer","Challenges and emerging strategies for genome-wide evaluation of loss of imprinting in cancer","","Review examining why assessing genomic imprinting loss (LOI) in cancer is technically complex and how emerging methodologies can address key limitations. It introduces imprinting biology, dysregulation, and relevant clinical findings, then summarizes methods for characterizing normal imprinting and cancer-associated aberrations. It details interpretation barriers including tumor impurity, heterozygosity requirements to resolve maternal versus paternal alleles, and tissue- or transcript-specific imprinting patterns, and evaluates state-of-the-art approaches. The review highlights future single-cell and single-molecule integration to enable practical clinical testing.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/challenges-and-emerging-strategies-for-genome-wide-evaluation-of-loss-of-imprinting-in-cancer/353145/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/challenges-and-emerging-strategies-for-genome-wide-evaluation-of-loss-of-imprinting-in-cancer/353145.png","ImageObject",300,407,{"name":92,"@type":93},"Franzy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is genomic imprinting and how does it differ from typical gene expression?","Question",{"text":112,"@type":113},"Genomic imprinting is monoallelic expression of a gene based on parental origin, unlike the typical biallelic expression assumed for autosomal genes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why is evaluating loss of imprinting (LOI) in cancer technically challenging?",{"text":117,"@type":113},"Assessment is complicated by factors such as tumor impurity, the need for heterozygosity to distinguish maternal and paternal alleles, and tissue- or transcript-specific imprinting patterns.",{"name":119,"@type":110,"acceptedAnswer":120},"What future methodological direction does the review emphasize for imprinting studies?",{"text":121,"@type":113},"It emphasizes integrating single-cell and single-molecule-based methods to more straightforwardly characterize imprinting dysregulation, identify underlying causes, and support clinical test development.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353145,1790854595,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","OPEN ACCESS  \n*CORRESPONDENCE  \nTim De Meyer,  \n [tim.demeyer@ugent.be](tim.demeyer@ugent.be)  \n†These authors share senior authorship  \nRECEIVED 02 April 2026  \nREVISED 27 May 2026  \nACCEPTED 29 May 2026  \nPUBLISHED 09 June 2026  \nCITATION  \nAmin MT, Coussement L and De Meyer T (2026) Challenges and emerging strategies for genome-wide evaluation of loss of imprinting in cancer.  \nBr. J. Biomed. Sci. 83:16709 .  \ndoi: 10.3389/bjbs.2026.16709  \nCOPYRIGHT  \n© 2026 Amin, Coussement and De Meyer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nTYPE Review  \nPUBLISHED 09 June 2026 DOI 10.3389/bjbs.2026.16709  \nChallenges and emerging strategies for genome-wide evaluation of loss of imprinting in cancer  \nMuhammad Talal Amin 1,2,3, Louis Coussement 1,2† and Tim De Meyer 1,2,4*†  \n1Department of Data Analysis and Mathematical Modelling, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium, 2Cancer Research Institute Ghent (CRIG), Ghent, Belgium, 3Department of Bioscience and Technology, Khwaja Fareed University of Engineering and Information Technology, Rahim Yar Khan, Pakistan, 4Bioinformatics Institute Ghent N2N, Ghent University, Ghent, Belgium  \nGenomic imprinting is the phenomenon in which only a single allele of a gene is expressed based on its parental origin, thereby deviating from the typical biallelic expression of autosomal genes. It is meticulously controlled by epigenetic mechanisms, particularly DNA methylation. Imprinted loci are crucial for regulating growth during early development, and anomalies in imprinting can lead to congenital syndromes such as Beckwith-Wiedemann’s and Prader-Willi’s. Similarly, many cancers exhibit dysregulated imprinting patterns, putatively contributing to tumour growth. Yet, the assessment of imprinting in cancer is complex due to technical challenges, impeding clinical research and the translation of novel insight to the clinic. This review starts with a general introduction to imprinting, its (dys)regulation and key clinical findings in cancer and beyond. Then, we summarize common methods used to characterize normal imprinting and aberrations in cancer. Subsequently, we discuss how the interpretation of such findings is complicated by technical challenges, such as tumour impurity, the requirement for heterozygosity to distinguish between maternal and paternal alleles and the presence of tissue- and transcriptspecific imprinting patterns. We further delve into state-of-the-art methods able to mitigate these challenges. Finally, we discuss how future methodological innovations, particularly by integrating single-cell and singlemolecule based methods, may further facilitate a straightforward characterization of imprinting dysregulation and its underlying causes, and guide the development of clinical tests. Thus, by integrating recent advances and proposing innovative approaches, our review aims to provide a comprehensive overview for cancer researchers and clinicians to facilitate cancer imprinting research and its translation to the clinic.  \nKEYWORDS  \ncancer, genomic imprinting, loss of imprinting (LOI), multi-omics, single cell sequencing  \nIntroduction  \nGenomic imprinting is a unique epigenetic process that results in the monoallelic expression of a gene based on its parental origin. This contrasts classical Mendelian inheritance, which assumes that both alleles of the gene equally contribute to an organism’s phenotype [ 1, 2] . The earliest hints of imprinting emerged from studies on nuclear transplantation experiments in mice. Developmental biologists observed that  \nBriti","cbCainSn2hZHXI8x","https://ap.wps.com/l/cbCainSn2hZHXI8x","pdf",3847252,14,"English","# Introduction\n## Genomic imprinting and evolutionary explanations\n## Clinical relevance of LOI in cancer\n## Methods to characterize imprinting and aberrations\n## Technical challenges in data interpretation\n## Emerging state-of-the-art strategies and future directions","[{\"question\":\"What is genomic imprinting and how does it differ from typical gene expression?\",\"answer\":\"Genomic imprinting is monoallelic expression of a gene based on parental origin, unlike the typical biallelic expression assumed for autosomal genes.\"},{\"question\":\"Why is evaluating loss of imprinting (LOI) in cancer technically challenging?\",\"answer\":\"Assessment is complicated by factors such as tumor impurity, the need for heterozygosity to distinguish maternal and paternal alleles, and tissue- or transcript-specific imprinting patterns.\"},{\"question\":\"What future methodological direction does the review emphasize for imprinting studies?\",\"answer\":\"It emphasizes integrating single-cell and single-molecule-based methods to more straightforwardly characterize imprinting dysregulation, identify underlying causes, and support clinical test development.\"}]","Challenges and emerging strategies for genome-wide evaluation of loss of imprinting in cancer | PDF",1790103298,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8e2ba8b3ce2734ab7ceea7610b665c5.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e621d8da421c185222e6a593bec40331.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a98257884ee44e4040621e8b7a8af2e9.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa3ae8f5599bd7554ee24839d113a765.webp",980,1385]